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1st Editorial Decision 8 July 2015
Thank you much for submitting your manuscript to The EMBO Journal. I am sorry for the delay in getting back to you with a decision, but as it is a busy time it unfortunately took a bit longer than anticipated to get the full set of reports back.
I have now received the reports on your manuscript and they are provided below. The referees do appreciate the interest of the topic. However they also raise concerns that I am afraid preclude publication here at this stage. Referee #2 is positive and support publication as is. However, both referees #1 and 3 also find that the analysis has to be extended for consideration here. While referee #1 requests more mechanistic insight into the link between APP and NMDAR, referee #3 finds that further insight into the effects on learning and memory is needed. Referee #1 also points out issues regarding the electrophysiology.
Given these concerns, I am afraid that I can't offer to invite a revision at this stage as it is too unclear if the issues raised can be addressed. However, should you be able to extend the analysis along the lines as suggested, I am open to look at a resubmission. I should add that we don't require the full mechanism for how APP affects NMDAR, but some further molecular insight is needed. I should point out that for resubmissions that we do consider novelty at time of resubmission and if needed might involve new referee(s).
Referee #3:
Zou et al show that there is a functional link between APP and NMDA receptor induced spine morphology. The authors used an APP KO mouse model and looked at spine turnover rate (TOR), spine density and morphology. No difference was found in spine density between APP KO and WT mice, however, there were differences in spine elimination and formation with correlates to a significant reduction in TOR when APP is knocked out. Usually environmental enrichment increases spine density, however, this increase is not seen in the absence of APP suggesting APP plays a necessary role in enrichment induced spine formation. The author's next look at the relationship between APP and NMDA induced spine formation. The APP KO mice have a lower contribution of NMDA mediated currents in the generation of mEPSC. To verify the role of the NMDA receptor in this electrophysiological response they compared the expression levels of the NMDA receptor subunits in APP KO and WT mice and found they were significantly reduced in the absence of APP. Finally, they were able to recover the APP KO phenotype by treating mice with Dserine, an NMDA agonist. This data suggests that APP contributes to NMDA mediated synaptic dynamics. The findings linking APP to NMDA mediated spine morphology are novel and would be an excellent article in the EMBO Journal if authors connect this data to learning and memory deficits. The authors suggest in their discussion that APP's modulation of spine morphology may have a function in AD pathology and some experimental data could substantiate this claim. For example, the authors could look at changes in learning and memory in the APP KO mouse model when treated with D-serine using simple behavioral paradigms such as the Morris water maze, the Y maze and fear conditioning. We thank all the referees for comments with constructive suggestions. In the revised text, we have made necessary clarifications and provide additional experimental data requested along with the rebuttal of specific points made.
During the course of the revision we made the exciting finding that APP loss leads to a reduction of extracellular D-serine levels, which in turn cause the observed effects on dendritic spines. Therefore, we restructured the manuscript to focus on these mechanistic findings.
We removed the section on electrophysiology, as we found it technically too challenging to asses synaptic NMDA receptor function under adequately controlled conditions. The detailed explanations for these decisions are given in the answers to the reviewers' questions, below.
Similarly, we realized that using sAPPα knock-in mice to determine which APP cleavage products may mediate the described effects was based on a too simplistic model: Cleavage of the sAPPα fragment from the holoprotein may determine the specific extracellular location of that fragment, which is not necessarily recapitulated by the knock-in mouse model. Therefore, we opted to remove those data as well.
Referee #1:
I feel this work lacks mechanistic insight in to the role of APP. How does it link to reduction in NMDAR?
Response: As exogenous D-serine treatment has successfully rescued the deficits of spine plasticity in APP-KO mice, the mechanism of APP in maintaining spine plasticity may be directly related with D-serine. To test this hypothesis, we measured cortical extracellular and total D-serine concentrations by microelectrode biosensor recordings and HPLC, respectively. These results confirmed that extracellular D-serine levels are dysregulated in APP-KO mice (Fig. 4) . Combined with D-serine rescue experiments (Fig. 5) , our data clearly demonstrate that decreased extracellular D-serine is the mechanistic reason for impaired spine dynamics and adaptive plasticity in APP-KO mice. Figure 1G ? Response: We attempted to pharmacologically isolate AMPAR and NMDAR currents, as suggested by the reviewer. We found that the amplitudes of miniature NMDAR-mediated currents were too small to discern over the noise. Although the addition of extracellular glycine or d-serine may have increased the amplitudes, we were afraid, that these substances would mask the effects of endogenous d-serine which we discovered to play a critical downstream role in mediating the effects of APP knockout.
How did the authors draw regression line in
Furthermore, we attempted to record evoked EPSCs. However in the cortex, unlike in the hippocampus, no distinct fiber bundles can be stimulated to evoke EPSCs in specific cell populations. Rather, stimulation electrodes are placed in the cortex and the response from nearby neurons is recorded. The resultant EPSC amplitudes, however, are strongly affected by the distance of the recorded neuron from the stimulation electrode and possibly other factors, thus causing large variance in the recorded currents. In practice, this is typically controlled for by quantifying the NMDA/AMPA current ratio (cf. . Using that approach, we found no difference in NMDAR/AMPAR ratios between genotypes, suggesting that AMPAR function may be altered as well. Therefore, this approach is unsuitable to assess electrophyiological changes in NMDAR function.
As we lack the tools to investigate NMDAR function in these models in adequate detail, we preferred to leave out the electrophysiological data from this manuscript. Several previous studies showed effects of d-serine on NMDAR function, which we cite in the manuscript. EPSC were recorded in the presence of 50 µM picrotoxin and low extracellular Mg 2+ (0.5 mM). The cell was clamped at -90 mV for AMPAR currents and at +40 mV for NMDAR currents and stimulated via a nearby extracellular electrode. AMPAR and NMDAR current amplitudes were measured 10 and 40 ms after the stimulus artifact, respectively. B: NMDAR/AMPAR ratios.
Figure The same experiment must be done with WT. The rescue effect of D-serine is not contradictory to the author's idea but still does not fully support, given various biological effect implicated for APP.
Response: As requested, WT mice have been treated with D-serine as APP-KO mice (Supp. Fig. 1 ). Exogenous D-serine administration does not change spine dynamics and adaptive spine plasticity in WT mice. Response: We realized that using sAPPα knock-in mice to determine which APP cleavage products may mediate the described effects was based on a too simplistic model: Cleavage of the sAPPα fragment from the holoprotein may determine the specific extracellular location of that fragment, which is not necessarily recapitulated by the knock-in mouse model. Therefore, we opted to remove those data
P11 Line 11. Filser et al. Not listed in reference list.
Response: This section has been deleted in the revised manuscript
Referee #2:
Response: We thank this referee for his/her highly encouraging and positive remarks and greatly appreciate his/her interest in our study Referee #3:
The findings linking APP to NMDA mediated spine morphology are novel and would be an excellent article in the EMBO Journal if authors connect this data to learning and memory deficits.
The authors suggest in their discussion that APP's modulation of spine morphology may have a function in AD pathology and some experimental data could substantiate this claim.
Response: As suggested, we have performed novel objective recognition test in adult APP-KO mice (Fig. 6 ) and found that they do display memory deficits. Cognitive decline in APP-KO mice has been rescued after D-serine treatment over 5 weeks, illustrated by the fact that APP-KO mice treated with D-serine has explored the novel object significantly more. These results indicate impaired spine plasticity in APP knockout is associated with cognitive deficits.
nd Editorial Decision 24 March 2016
Thanks for submitting your manuscript to The EMBO journal. This is an invited resubmission of manuscript 92035.
Your manuscript has now been re-reviewed by referees #1 and 3. As you can see from their comments below the response is a bit mixed. Referee #3 raises issues regarding novelty and advance, while referee #1 is now more positive. Having evaluated all the comments carefully and discussed them further with referee #1 and colleagues, I have decided to invite a final revision. I have made comments below regarding the specific comments raised by referees:
Referee points: Karin: This is an important control that needs to be done.
Ref#3: Novelty issues
Karin: I don't see a major issue here. Maybe good to cite the papers and discuss.
Ref#3: removal of the electrophysiology data (also related to point above raised by ref#1).
Karin: Has anything changed regarding this? and is this something that you might be able to sort out? If not let's discuss further Ref#3: Identify the APP fragments that promote spine density.
Karin: Interesting point, but beyond the scope of this manuscript.
Why don't you send me a point-by-point response and then we can see the best way to move forward.
-
The 
Response to referees
1. Whether there is actually reduction in NMDA current.
The results in the previous version of this work were obtained by measuring spontaneous AMPA mEPSC at a holding potential of -65 mV and combined AMPA + NMDA mEPSC at -45 mV. This provided only indirect evidence of altered NMDA receptor (NMDA Rs) function. During the course of the revision, we tested evoked NMDA Rs and AMPA Rs currents at positive and negative potentials, as the reviewers had suggested. By employing this more direct method, we did not observe any change in the NMDA Rs /AMPA Rs current ratios (see figure below). We acknowledge that this result contrasts with previous observation describing altered NMDA Rs current in in vitro model of APP-deficiency (as mentioned in the previous discussion of this paper, referring to Hoe et al., 2009 [1] ). However, we suspect NMDA Rs function critically change between in vivo and in vitro conditions. More importantly, we unveiled the new findings that disrupted D-serine homeostasis is the underlying mechanism of impaired structural spine plasticity observed in APP-KO brain. Therefore, we opted to leave out these contradictory NMDA Rs current data from this manuscript, keeping our work focused on the study of parameters measured from the intact brain.
What is the mechanism leading to the reduction in extracellular but not total D-Serine.
We thank the referee for the opportunity to clarify our interpretation of the mechanism. The cause of reduced extracellular levels but increased total D-serine in our data is most likely related to a defective release of D-Serine containing vesicles in APP-deficient astrocytes. It has been shown that loss of APP modulates cytosolic calcium concentration and reduces ER calcium filling in astrocytes [2, 3] . Meanwhile, it is well documented that calcium signaling is critical for D-serine release from astrocytes [4] [5] [6] [7] . Together with our data, these evidences suggest that dysregulated calcium signaling in APP-KO astrocytes might decrease their ability to release D-serine in the extracellular space. At the same time, disrupted exocytosis in astrocytes likely triggers D-serine accumulation in intracellular vesicular pools, explaining why the total D-serine does not decrease in the brain, but actually increase compared to control mice. Note that the total D-serine concentration measured by HPLC is actually more than 99% intracellular [8] . The only D-serine storage mechanism presently described in literature is storage in intracellular vesicles of astrocytes (for a review [7] ). In contrast, D-serine synthesized in neurons is not stored, but released through Asc1 transporters and eliminated through the blood or taken up by astrocytes. Therefore, D-serine accumulation in astrocytic vesicles would result in increased total brain D-serine levels as measured by HPLC. We have included these considerations in the modified discussion.
Whether there is indeed recovery of extracellular D-serine concentration by oral administration.
To figure out if oral administration of D-serine indeed recovers extracellular D-serine concentration in APP-KO mice, we have treated APP-KO mice with exogenous D-serine for five weeks and assessed cognition by the novel object paradigm and spine dynamics by two-photon imaging. We have found that after chronic D-serine treatment, the extracellular D-serine concentration in APP-KO mice is not significantly different as compared with WT mice (Fig.4) . Surprisingly, the total Dserine level in APP-KO mice is also normalized after exogenous D-serine treatment. Thus, these data suggest that oral administration of D-serine not only successfully recovers extracellular Dserine concentration in APP-KO mice, but also restores D-serine homeostasis. Unfortunately, we have no experimental evidence that might explain why providing APP-KO mice chronically with exogenous D-serine restores normal total amounts of D-serine in the brain. However, our observations clearly link APP depletion to physiological alteration of production, maintenance and/or release of D-serine. To dissect further each single component responsible of this unbalanced homeostasis, it might need to perform in vitro approaches. This may, however, in turn compromise the pathophysiological condition where this phenomenon is detectable (an intact parenchymal environment). As we pointed this out in the manuscript, any further in vitro investigations about the role of D-serine in APP-deficient model need to consider these limitations
Whether the reduction is specific to D-serine or not
In our new version of the paper, we included the quantification of L-serine by HPLC, the precursor of D-serine. The total amount of L-Serine changed following the same pattern of D-serine: compared to controls, it is higher in APP-KO mice, and normalized after chronic D-serine treatment in the drinking water. Both of them, D-serine and L-serine, accumulate probably because the system detects the deficiency of extracellular D-serine and tries to compensate it by increasing its production. In our prospective, this is another indication that points the compromised D-serine release machinery to be the cause of serine accumulation, but not to its production. At the end, the restoration of normal extracellular D-serine we described in the intact brain of APP-KO mice allows D-serine homeostasis to be reverted into physiological conditions. Unfortunately, our in vivo approaches still cannot explain the entire mechanism and further investigations are needed to dissect the specific components resulting in this restoration process, which may also involve in vitro studies. It is also noteworthy that in vitro condition may not guarantee the physiological balance between intracellular and extracellular amino acids concentrations, important for a functional tonic and phasic D-serine release. Indeed, these papers have investigated the relationship between APP fragments and D-serine release. Interestingly, these results have confirmed that APP fragments increases D-serine release, which seem to be in line with our findings that loss of APP decreases D-serine release. We have updated our manuscript with this information (Discussion, paragraph 4). To our knowledge, this study is not only the first to demonstrate that D-serine release is down-regulated in the absence of APP in vivo, but also shows the functional consequences associated with this. Here we provide direct evidence that decreased spine dynamics in APP-KO mice lead to impaired cognition. We thank the referee for this comment that prompted us examine cognitive behavior, which lead to this exciting finding 2. Another concern is that the authors chose to eliminate data in which the reviewer has asked about in this revised manuscript, rather than to experimentally address them.
P2 line
Actually, we performed the experiments in the way they had been suggested by the referees. However, the results do not support our previous conclusion that NMDA Rs currents are reduced in APP-KO. In light of the new data, we admit that our previous data on mEPSC are not supportive enough to prove altered NMDA Rs function. Since the novel results do not add any insight into the mechanism of abnormal spine plasticity in APP knockout, we decided to remove the data from the revised manuscript and present these data only to the reviewers (see also reply to referee' 1, point 1). We completely agree with the referee that APP fragments and their relative proteins need to be investigated for their roles in modulating spine density and dynamics. We have been working on this topic several years and we will definitely continue this work. We really appreciate the interest of the referee on our work. 1. Data the data were obtained and processed according to the field's best practice and are presented to reflect the results of the experiments in an accurate and unbiased manner. figure panels include only data points, measurements or observations that can be compared to each other in a scientifically meaningful way. graphs include clearly labeled error bars for independent experiments and sample sizes. Unless justified, error bars should not be shown for technical replicates. if n< 5, the individual data points from each experiment should be plotted and any statistical test employed should be justified Please fill out these boxes ê (Do not worry if you cannot see all your text once you press return) a specification of the experimental system investigated (eg cell line, species name). the assay(s) and method(s) used to carry out the reported observations and measurements an explicit mention of the biological and chemical entity(ies) that are being measured. an explicit mention of the biological and chemical entity(ies) that are altered/varied/perturbed in a controlled manner.
In addition, this lab has investigated
the exact sample size (n) for each experimental group/condition, given as a number, not a range; a description of the sample collection allowing the reader to understand whether the samples represent technical or biological replicates (including how many animals, litters, cultures, etc.).
Please ensure that the answers to the following questions are reported in the manuscript itself. We encourage you to include a specific subsection in the methods section for statistics, reagents, animal models and human subjects. 
C--Reagents

Captions
The data shown in figures should satisfy the following conditions:
Source Data should be included to report the data underlying graphs. Please follow the guidelines set out in the author ship guidelines on Data Presentation. a statement of how many times the experiment shown was independently replicated in the laboratory.
Any descriptions too long for the figure legend should be included in the methods section and/or with the source data.
